What You Should Know:
– On/Go (by Intrivo) – the health tech startup behind COVID test kits that have helped hundreds of millions of people – has launched a Test to Treat solution for at-home Paxlovid antiviral access, plus a virtual long COVID clinic.
– While some studies have shown Paxlovid may reduce risk of hospitalization and death by 89%, only 11% of Americans who recently had COVID were given antiviral therapy, likely due to accessibility issues. Paxlovid treatment must begin within 5 days after symptoms begin, so timing matters. On/Go Test to Treat is a rapid, at-home solution in the On/Go mobile app that delivers free Paxlovid antiviral medication to eligible COVID patients’ homes within hours, at no cost.
– On/Go has also launched a new, virtual long COVID service to help the 1 in 5 people who contract COVID and suffer from lingering symptoms. It includes an easy-to-use symptom checker and live telemedicine video calls with clinicians who have experience with long COVID.
